UK Percutaneous Coronary Intervention Market Research Report By Product Type (Coronary Stents, Ballon Catheters, Coronary Guidewires, Guiding Catheters, Guiding Sheaths, Diagnostic Catheters, Crossing Catheters, Inflation Device, Guidance System, Peripheral Thrombectomy System, Embolic Protection System, Accessories), By Vascular Access (Radial, Femoral) and By End User (Hospitals Clinics, Ambulatory Surgical Centers, Others)-Forecast to 2035

UK Percutaneous Coronary Intervention Market Overview

As per MRFR analysis, the UK Percutaneous Coronary Intervention Market Size was estimated at 398.76 (USD Million) in 2023.The UK Percutaneous Coronary Intervention Market is expected to grow from 438.75 (USD Million) in 2024 to 1,096.88 (USD Million) by 2035. The UK Percutaneous Coronary Intervention Market CAGR (growth rate) is expected to be around 8.687% during the forecast period (2025-2035).

Key UK Percutaneous Coronary Intervention Market Trends Highlighted

An aging population and rising cardiovascular disease incidence are driving major market trends in the UK percutaneous coronary intervention (PCI) industry. Since heart-related problems continue to be a major health concern in the UK, the National Health Service (NHS) highlights the need for efficient treatment alternatives.

Minimally invasive procedures are becoming more and more popular because they satisfy patients' desires for quicker recovery times and shorter hospital stays.

PCI is becoming more widely used as a result of improvements in procedural success rates brought about by technological developments in imaging and catheter design. There are clear development prospects in the UK industry as healthcare providers look to reduce expenses and enhance patient outcomes.

Given the NHS's ongoing efforts to deliver effective care, hospitals and medical device makers can work together to create creative solutions.

Furthermore, early detection and treatment of coronary artery disorders are being encouraged by the public's increased health consciousness and adoption of preventative measures, which will ultimately lead to an expansion of the PCI market.

Adopting dual antiplatelet therapy and other adjuvant treatments in addition to PCI has been increasingly popular in recent years as a way to enhance patient recovery and lower the risk of complications. As medical professionals use genetic and biomarker testing to customize treatment regimens for patients, the emphasis on personalized medicine is also crucial.

In keeping with developments in precision medicine, this movement guarantees safer and more effective interventions. With an emphasis on improved patient experience and cardiovascular health outcomes, these trends and drivers all point to a strong market environment for PCI in the UK.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

UK Percutaneous Coronary Intervention Market Drivers

Increasing Incidence of Cardiovascular Diseases

Cardiovascular diseases (CVDs) represent a significant health challenge in the UK, with statistics indicating that CVDs are responsible for nearly one in four deaths. The British Heart Foundation reports that approximately 7.4 million people in the UK are living with heart and circulatory diseases.

As the population ages, the prevalence of these diseases is expected to rise, subsequently increasing the demand for surgical intervention options, including percutaneous coronary interventions (PCIs). The UK Percutaneous Coronary Intervention Market is poised for growth as healthcare providers and patients explore more effective treatment options in light of advancing medical technologies.

Initiatives from organizations like the NHS and Heart Foundation aim to improve the treatment landscape, actively contributing to an environment that supports the expansion of PCI capabilities. Furthermore, with ongoing developments in minimally invasive techniques that enhance patient recovery, the market for PCI is likely to expand significantly as patients seek safer and more effective coronary treatments.

Technological Advancements in PCI Procedures

Recent technological advancements in the UK Percutaneous Coronary Intervention Market have introduced innovations such as bioresorbable stents and improved imaging techniques, which play a crucial role in enhancing the efficacy and safety of procedures.

The National Institute for Health and Care Excellence (NICE) has supported the adoption of these technologies, providing guideline updates that mission to improve patient outcomes. Emerging techniques like optical coherence tomography (OCT) have significantly improved visualization during procedures, allowing for optimized stent placement and reduced complications.

As these technologies become more widely adopted by clinical practices across the UK, the overall market for PCI is projected to grow steadily in the coming years.

Increased Healthcare Expenditure on Cardiovascular Treatments

The UK government has steadily increased healthcare expenditure, with a notable focus on improving cardiovascular health. The NHS Long-Term Plan outlines a commitment to dedicate resources toward innovative treatment options, including percutaneous coronary interventions.

In 2020, healthcare spending accounted for almost 10% of the UK's GDP, indicating a strong commitment to disease management and prevention. This focus translates into enhanced funding for PCI procedures, resulting in a more robust UK Percutaneous Coronary Intervention Market.

The growing emphasis on preventive care and treatment accessibility aims to reduce the burden of cardiovascular diseases, further stimulating market growth.

Aging Population Driving Market Demand

The aging population in the UK is a significant driver for the UK Percutaneous Coronary Intervention Market. According to the Office for National Statistics, the percentage of people aged 65 and over in the UK is projected to increase from 18% in 2019 to 24% by 2043.

This demographic shift leads to higher prevalence rates of chronic conditions such as coronary artery disease, requiring interventions like PCI. As older adults are more susceptible to heart diseases, the demand for effective coronary treatment options is expected to soar.

This increased need will likely drive growth in the PCI sector as healthcare providers seek to meet the requirements of this expanding population segment.

UK Percutaneous Coronary Intervention Market Segment Insights

Percutaneous Coronary Intervention Market Product Type Insights

The UK Percutaneous Coronary Intervention Market exemplifies a vital role in modern cardiovascular care, encompassing various product types that cater to different procedural needs within cardiac interventions.

Among these, Coronary Stents have carved out a significant presence, primarily due to their effectiveness in maintaining arterial patency and preventing restenosis, which is crucial for improving patient outcomes post-procedure.

Ballon Catheters follow closely, as they serve an essential role in achieving arterial dilation, complementing stenting procedures and enhancing the efficacy of angioplasty techniques that are widely performed across the UK.

Additionally, Coronary Guidewires are imperative in navigating the complex anatomy of coronary vessels during interventions, contributing to successful procedural outcomes by ensuring accurate positioning of devices.

Likewise, Guiding Catheters and Guiding Sheaths play an instrumental role in providing access and stabilizing the delivery of interventional devices into coronary arteries, a necessity for achieving precision during interventions.

Diagnostic Catheters, which are used for imaging and hemodynamic assessments, underscore the importance of accurate diagnosis leading to effective treatment strategies. The inclusion of Crossing Catheters reflects the increasing focus on advancing techniques to cross chronic total occlusions, addressing a challenging aspect of coronary artery disease treatment.

Other supportive devices like Inflation Devices are critical for effective deployment of balloons and stents, while Guidance Systems that offer real-time imaging and navigation aid are becoming more prevalent, enhancing procedural efficiency and safety.

The Peripheral Thrombectomy System, along with Embolic Protection Systems, further demonstrates the focus on protecting patients from complications during interventions and minimizing risks associated with thrombosis.

It’s worth noting the substantial importance of Accessories in facilitating various procedural components, evidencing their contribution towards enhancing the overall quality of interventions.

In summary, the diverse range of product types in the UK Percutaneous Coronary Intervention Market not only illustrates significant advancements within the industry but also indicates ongoing innovation driven by the aim to improve patient care and procedural outcomes in an evolving landscape of cardiovascular health management across the region.

With the healthcare ecosystem increasingly integrating advanced technologies and techniques, the prospects for growth in these product categories remain promising, responding effectively to the rising prevalence of coronary artery diseases and the need for efficient treatment options.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Percutaneous Coronary Intervention Market Vascular Access Insights

The Vascular Access segment within the UK Percutaneous Coronary Intervention Market plays a crucial role in defining the success of interventional cardiac procedures. This segment provides the necessary means for accessing the vascular system, which is essential for delivering therapeutic interventions efficiently.

Notably, the Radial access technique has gained traction in the UK due to its favorable outcomes, including reduced complication rates and quicker patient recovery, thus facilitating smoother procedural workflows. The Femoral access method, while traditional, still holds significant importance, particularly in cases that require extensive intervention, highlighting its relevance in complex procedures.

As healthcare systems in the UK continue to evolve, adopting innovative techniques, both pathways ensure a comprehensive approach to vascular access, catering to diverse patient needs.

Overall, advancements in technology and clinician training have bolstered the efficacy and safety of vascular access techniques, making them a pivotal focus within the UK Percutaneous Coronary Intervention Market.

Percutaneous Coronary Intervention Market End User Insights

The UK Percutaneous Coronary Intervention Market, focusing on the End User segment, showcases a diverse landscape characterized by various healthcare settings. Hospitals and clinics stand out as critical contributors due to their capacity to incorporate advanced surgical technologies and skilled personnel, thus meeting a significant portion of the growing demand for interventional procedures.

Ambulatory surgical centers are also gaining traction, providing patients with a more streamlined and cost-effective option for surgical treatments, which aligns with the NHS's initiatives to enhance patient care efficiency. Additionally, the 'Others' category encompasses a mix of facilities that play niche roles in delivering specialized care, further enriching the market landscape.

This segmentation reflects broader trends within the UK healthcare ecosystem, particularly the shift towards more accessible and efficient healthcare options driven by demographic changes and an increasing prevalence of cardiovascular diseases.

Overall, each segment carries importance and contributes to the continuous growth and evolution of the UK Percutaneous Coronary Intervention Market, as healthcare providers adapt to meet the needs of a dynamic patient population.

UK Percutaneous Coronary Intervention Market Key Players and Competitive Insights

The UK Percutaneous Coronary Intervention Market is a dynamic and evolving sector within the medical device industry, characterized by a competitive landscape that encompasses a range of companies specializing in cardiovascular devices and services.

The market has witnessed significant advancements due to technological innovations, increased prevalence of cardiovascular diseases, and a growing aging population seeking effective treatment options.

Key players within this market strive to enhance patient outcomes through the development of innovative products such as stents, balloon catheters, and other interventional devices that facilitate minimally invasive procedures.

Competitive intelligence in this sector highlights the importance of product differentiation, regulatory compliance, and customer relationships as companies continuously seek to establish their market presence while addressing the unique needs of healthcare providers and patients in the UK.

B. Braun Melsungen AG holds a prominent position in the UK Percutaneous Coronary Intervention Market, leveraging its robust product portfolio and commitment to innovation. The company is recognized for its comprehensive range of medical devices specifically designed to improve the efficacy of interventional procedures in cardiology.

B. Braun has made significant investments in research and development to ensure that its offerings meet the stringent requirements of healthcare regulations while delivering high-quality solutions to cardiovascular specialists.

The company's strengths lie in its established brand reputation, extensive distribution channels, and a strong focus on customer support, which collectively enhance its competitive edge in the UK market. B. Braun's commitment to education and training for healthcare professionals further establishes its role as a trusted partner in the percutaneous coronary intervention sector.

Terumo Corporation plays a crucial role in the UK Percutaneous Coronary Intervention Market, highlighted by its advanced technologies and product innovations tailored for cardiovascular treatment. The company provides a wide array of medical devices, including high-performance guidewires, balloon catheters, and stents, which facilitate minimally invasive procedures central to percutaneous interventions.

Terumo's market presence in the UK is reinforced by its strategic collaborations and partnerships that drive research initiatives and expand its product offerings. The company’s strength lies in its focus on quality assurance, ongoing product improvements, and an emphasis on meeting the specific needs of healthcare providers and patients.

Through various mergers and acquisitions, Terumo has enhanced its capabilities in the cardiovascular device sector, enabling it to deliver cutting-edge solutions that align with the evolving demands of the UK healthcare landscape. The combination of innovative technology, strong market presence, and dedication to patient-centered solutions positions Terumo as a significant player in this competitive market.

Key Companies in the UK Percutaneous Coronary Intervention Market Include

• B. Braun Melsungen AG


• Terumo Corporation


• LivaNova


• Johnson and Johnson


• Hansen Medical


• Boston Scientific


• Siemens Healthineers


• Stryker Corporation


• Philips


• eV3


• Accelerated Care Plus


• Abbott Laboratories


• Medtronic


• Cardinal Health


• Cook Medical

UK Percutaneous Coronary Intervention Market Developments

Recent developments in the UK Percutaneous Coronary Intervention Market have highlighted significant advancements and trends among leading players, particularly B. Braun Melsungen AG, Terumo Corporation, Abbott Laboratories, and Medtronic.

With an ongoing emphasis on enhancing patient outcomes, there is a notable uptick in the adoption of innovative PCI technologies, influenced by the increasing prevalence of coronary artery diseases in the UK. In terms of market valuation, growth has been propelled by rising investments in research and development, with major companies actively seeking to expand their product portfolios.

Notable mergers and acquisitions in the sector include Abbott Laboratories acquiring a strategic interest in a cardiac device startup in September 2021, enhancing their capabilities in catheter technologies. Similarly, Boston Scientific's acquisition of a smaller tech firm specializing in advanced imaging for PCI in May 2022 has strengthened their competitive positioning.

In the last couple of years, initiatives from the UK’s National Health Service to improve the efficiency of PCI procedures are shaping the landscape by promoting best practices and technology integration. These developments signify a dynamic market climate responding to both technological advances and healthcare demands within the UK.

UK Percutaneous Coronary Intervention Market Segmentation Insights

UK Percutaneous Coronary Intervention Market Product Type Outlook

• Coronary Stents


• Ballon Catheters


• Coronary Guidewires


• Guiding Catheters


• Guiding Sheaths


• Diagnostic Catheters


• Crossing Catheters


• Inflation Device


• Guidance System


• Peripheral Thrombectomy System


• Embolic Protection System


• Accessories

UK Percutaneous Coronary Intervention Market Vascular Access Outlook

• Radial


• Femoral

UK Percutaneous Coronary Intervention Market End User Outlook

• Hospitals Clinics


• Ambulatory Surgical Centers


• Others

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	398.76(USD Million)
MARKET SIZE 2024	438.75(USD Million)
MARKET SIZE 2035	1096.88(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	8.687% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	B. Braun Melsungen AG, Terumo Corporation, LivaNova, Johnson and Johnson, Hansen Medical, Boston Scientific, Siemens Healthineers, Stryker Corporation, Philips, eV3, Accelerated Care Plus, Abbott Laboratories, Medtronic, Cardinal Health, Cook Medical
SEGMENTS COVERED	Product Type, Vascular Access, End User
KEY MARKET OPPORTUNITIES	Technological advancements in PCI devices, Growing cardiovascular disease prevalence, Increasing demand for minimally invasive procedures, Rising healthcare expenditure in UK, Expanding patient awareness and education
KEY MARKET DYNAMICS	Aging population, Increasing cardiovascular diseases, Advances in technology, Growing awareness of PCI, Rising healthcare expenditure
COUNTRIES COVERED	UK